News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
408,448 Results
Type
Article (30291)
Company Profile (91)
Press Release (378062)
Multimedia
Podcasts (115)
Webinars (14)
Section
Business (128417)
Career Advice (1165)
Deals (19833)
Drug Delivery (132)
Drug Development (56446)
Employer Resources (95)
FDA (9954)
Job Trends (8925)
News (204509)
Policy (23085)
Tag
2025 Best Places to Work (8)
2026 Best Places to Work (16)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (1)
40 Under 40 (3)
Academia (1513)
Accelerated approval (49)
ADA (17)
Adcomms (26)
Allergies (181)
Alliances (30141)
ALS (144)
Alzheimer's disease (1418)
Antibody-drug conjugate (ADC) (401)
Approvals (10504)
Artificial intelligence (506)
ASCO (170)
Autoimmune disease (224)
Automation (35)
Bankruptcy (197)
Belgium (15)
Best Places to Work (6755)
BIO (34)
Biologics (76)
BIOSECURE Act (14)
Biosimilars (238)
BioSpace Insights (90)
Biotechnology (46)
Bispecific (30)
Bladder cancer (128)
Brain cancer (68)
Breast cancer (452)
Cancer (3901)
Cardiovascular disease (385)
Career advice (1019)
Career pathing (33)
CAR-T (193)
CDC (53)
CDMO (152)
Celiac Disease (5)
Cell-line development (1)
Cell therapy (538)
Cervical cancer (37)
Clinical research (49542)
Collaboration (1594)
Commercialization (43)
Company closure (4)
Compensation (620)
Complete response letters (74)
COVID-19 (2476)
CRISPR (88)
CRO (4)
C-suite (1005)
Cystic fibrosis (89)
Data (6185)
Decentralized trials (3)
Denatured (23)
Depression (113)
Dermatology (127)
Diabetes (435)
Diagnostics (2994)
Digital health (32)
Diversity (6)
Diversity, equity & inclusion (33)
Drug discovery (297)
Drug pricing (171)
Drug shortages (29)
Duchenne muscular dystrophy (264)
Earnings (45952)
Editorial (55)
Employer branding (10)
Employer resources (94)
ESMO (207)
Events (57676)
Executive appointments (814)
Eye disease (21)
FDA (12903)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (4)
Friedreich's ataxia (18)
Frontotemporal dementia (25)
Funding (1131)
Gene editing (159)
Generative AI (56)
Gene therapy (559)
GLP-1 (811)
Government (3306)
Grass and pollen (7)
Guidances (269)
Healthcare (8386)
Hematology (129)
HIV (74)
Huntington's disease (51)
Idiopathic pulmonary fibrosis (4)
IgA nephropathy (93)
Immunology and inflammation (194)
Immuno-oncology (82)
Indications (205)
Infectious disease (2821)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (130)
Intellectual property (213)
Interviews (203)
IPO (8084)
IRA (45)
Job creations (2408)
Job search strategy (854)
JPM (43)
Kidney cancer (19)
Kidney disease (105)
Labor market (73)
Layoffs (343)
Leadership (35)
Legal (6673)
Licensing (100)
Liver cancer (52)
Longevity (48)
Lung cancer (537)
Lung diease (9)
Lymphoma (308)
Machine learning (30)
Management (33)
Manufacturing (942)
Marketing (30)
MASH (130)
Medical affairs (4)
Medical device (3782)
Medtech (3864)
Melanoma (128)
Mergers & acquisitions (12616)
Metabolic disorders (1146)
Middle East (2)
mRNA (225)
Multiple sclerosis (161)
Multispecific (1)
NASH (15)
Netherlands (16)
Neurodegenerative disease (323)
Neuropsychiatric disorders (88)
Neuroscience (2595)
Neurotech (2)
NextGen: Class of 2026 (2999)
Non-profit (2214)
Now hiring (34)
Obesity (537)
Opinion (250)
Ovarian cancer (161)
Pain (206)
Pancreatic cancer (208)
Parkinson's disease (262)
Partnered (20)
Patents (474)
Patient advocacy (7)
Patient recruitment (454)
Patient selection (57)
Peanut (61)
People (36630)
Peptides (30)
Pharmaceutical (37)
Pharmacy benefit managers (24)
Phase 1 (14085)
Phase 2 (21308)
Phase 3 (17906)
Pipeline (8490)
Policy (265)
Postmarket research (1942)
Preclinical (6059)
Press Release (36)
Prostate cancer (207)
Psychedelics (61)
Radioligand (1)
Radiopharmaceuticals (265)
Rare diseases (1006)
Real estate (3202)
Recruiting (39)
Regenerative medicine (14)
Regulatory (17701)
Reports (35)
Research institute (1446)
Resumes & cover letters (174)
Rett syndrome (43)
RNA editing (15)
RSV (99)
Saudi Arabia (1)
Schizophrenia (137)
Series A (191)
Series B (120)
Series C (1)
Service/supplier (2)
Sickle cell disease (95)
Special edition (20)
Spinal muscular atrophy (157)
Sponsored (25)
Startups (2155)
State (2)
Stem cells (6)
Stomach cancer (17)
Substance use disorders (13)
Supply chain (101)
Switzerland (20)
Tariffs (88)
The Weekly (90)
Vaccines (1211)
Venture capital (88)
Weight loss (359)
Wet AMD (8)
Women's health (100)
Worklife (12)
Date
Last 7 days (359)
Last 30 days (1801)
Last 365 days (16321)
2026 (15076)
2025 (16566)
2024 (19289)
2023 (21857)
2022 (30126)
2021 (32025)
2020 (30001)
2019 (24070)
2018 (18540)
2017 (19115)
2016 (18621)
2015 (21405)
2014 (16883)
2013 (14035)
2012 (14903)
2011 (15623)
2010 (14356)
Location
Africa (545)
Alabama (36)
Alaska (2)
Arizona (176)
Arkansas (6)
Asia (28203)
Australia (4425)
California (7875)
Canada (2782)
China (1262)
Colorado (361)
Connecticut (315)
Delaware (297)
Europe (63512)
Florida (1407)
Georgia (223)
Hawaii (4)
Idaho (18)
Illinois (773)
India (122)
Indiana (519)
Iowa (7)
Japan (560)
Kansas (106)
Kentucky (36)
Louisiana (24)
Maine (36)
Maryland (1024)
Massachusetts (5797)
Michigan (122)
Minnesota (340)
Mississippi (3)
Missouri (83)
Montana (13)
Nebraska (9)
Nevada (64)
New Hampshire (26)
New Jersey (2817)
New Mexico (14)
New York (2313)
North Carolina (1161)
North Dakota (3)
Northern California (3963)
Ohio (179)
Oklahoma (8)
Oregon (20)
Pennsylvania (1769)
Puerto Rico (25)
Rhode Island (31)
South America (748)
South Carolina (27)
South Dakota (1)
Southern California (3281)
Tennessee (122)
Texas (1053)
United States (29246)
Utah (162)
Vermont (1)
Virginia (276)
Washington D.C. (56)
Washington State (629)
West Virginia (1)
Wisconsin (102)
Wyoming (4)
408,448 Results for "neovii pharmaceuticals ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MustGrow Receives First Milestone Payment from Bayer AG
• Bayer AG has paid MustGrow the first development milestone payment. • The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow’s mustard-based biocontrol technologies in Europe, Middle East and Africa.
August 21, 2026
·
6 min read
Press Releases
Claros Technologies Announces Continued Commercial Expansion into Europe and Entry into Pharmaceutical Manufacturing with a Successful PFAS Destruction Pilot at Bachem AG
September 22, 2026
·
5 min read
Business
Neovii and Fosun Pharma Enter Into an Exclusive Agreement
Neovii Pharmaceuticals AG and Shanghai Fosun Pharmaceutical Industry Development Co. Ltd have entered into an exclusive agreement, under which Neovii has granted Fosun Pharma Industry an exclusive license to develop and commercialize Neovii’s Grafalon® in Chinese Mainland, Hong Kong SAR, Macau SAR and Taiwan region.
September 7, 2022
·
6 min read
Press Releases
Mirum Pharmaceuticals Announces Positive Results from Cohort 2 of the Pivotal PROGRESS Study of ATEBRIOZ™ (zilurgisertib) in Pediatric Patients Aged 6 to <12 Years with Fibrodysplasia Ossificans Progressiva
October 26, 2026
·
10 min read
Press Releases
MustGrow Announces “Fireside Chat” Webcast with Bayer AG
October 26, 2026
·
3 min read
Press Releases
Revel Pharmaceuticals and Collaborators Report Enzymatic Reversal of a Chemical Hallmark of Aging in Human Tissue
July 14, 2026
·
2 min read
Press Releases
PolyBio Announces Inaugural Convergence Summit on Pathogen Persistence Across Chronic Disease and Aging
November 16, 2026
·
3 min read
Funding
NewLimit snags $435M after seeing age reversal in human liver cells
NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells.
June 3, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity
September 22, 2026
·
7 min read
Press Releases
nference and Novo partner to advance understanding of cardiometabolic disease and healthy ageing
November 18, 2026
·
3 min read
1 of 40,845
Next